Cebranopadol Effects on Ventilatory Drive, Central Nervous System (CNS) and Pain.
Clinical trial NCT05491785 · COMPLETED
Trial details
- NCT number
- NCT05491785
- Sponsor
- Tris Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-29
- Primary completion
- 2023-03-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.